Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Ranibizumab biosimilar by Incepta Pharmaceuticals for Diabetic Macular Edema: Likelihood of Approval
Ranibizumab biosimilar is under clinical development by Incepta Pharmaceuticals and currently in Phase III for Diabetic Macular Edema. According to...